MCEDC Interview: Greg Merril, CEO of Adaptive Phage Therapeutics
Adaptive Phage Therapeutics’ CEO, Greg Merril, was featured this week in MCEDC’s Built For Bio Video Series. David Petr, CEO of MCEDC, discovers how Greg’s clinical-stage company in Montgomery County, MD is using bacteria phage to combat the worldwide crisis in multi-drug resistant bacterial infections, one of the biggest threats to humankind.
Originally posted: https://thinkmoco.com/built-for-bio/video/phage
Latest posts by Chris Frew (see all)
- Serial Entrepreneurs of the Biohealth Capital Region - September 17, 2019
- New Pediatric Rare Disease Company, Abri Science, Launches in Baltimore to address Phenylketonuria (PKU) - September 17, 2019
- Immunomic Therapeutics Appoints Harvard’s Brain Tumor Expert, Dr. E. Antonio Chiocca, to its Scientific Advisory Board - September 17, 2019